In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation. — CFSMEATLAS
In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
Maes, Michael, Ringel, Karl, Kubera, Marta et al. · Journal of affective disorders · 2013 · DOI
Quick Summary
This study found that people with ME/CFS often develop antibodies (immune proteins) against serotonin, a chemical messenger in the brain. These antibodies were linked to higher levels of inflammation, signs of bacteria leaking from the gut, and worse symptoms including pain, fatigue, brain fog, and mood changes. The findings suggest ME/CFS involves immune system problems that may contribute to the condition's core symptoms.
Why It Matters
This study provides evidence that ME/CFS involves specific immune dysregulation against serotonin, linking three known disease mechanisms (autoimmunity, inflammation, and gut barrier dysfunction). Understanding these interconnected pathways may eventually lead to targeted treatments and biomarker-based diagnostics for ME/CFS patients who currently lack objective diagnostic tests.
Observed Findings
Anti-5-HT antibody positivity was present in 61.5% of ME/CFS patients versus 13.9% of chronic fatigue patients and 5.7% of controls (p<0.001).
ME/CFS patients with anti-5-HT antibodies showed significantly elevated TNFα, IL-1, and neopterin compared to seronegative ME/CFS patients.
IgA responses to Gram-negative bacterial lipopolysaccharide were increased in antibody-positive ME/CFS patients, suggesting bacterial translocation.
Anti-5-HT antibody positivity was significantly associated with hyperalgesia, fatigue, neurocognitive impairment, autonomic symptoms, sadness, and flu-like malaise.
Inferred Conclusions
5-HT autoimmune activity is a distinguishing immunological feature of ME/CFS compared to non-ME/CFS chronic fatigue and healthy controls.
Increased 5-HT autoimmunity is linked to activation of pro-inflammatory pathways and bacterial translocation, suggesting these mechanisms may drive or perpetuate autoimmune responses.
ME/CFS is fundamentally a neuro-immune disorder with measurable immune dysregulation against a key neurotransmitter.
5-HT autoimmune activity may mechanistically contribute to the multisystem symptom profile of ME/CFS.
Remaining Questions
Is the anti-5-HT autoimmunity a cause, consequence, or bystander in ME/CFS pathophysiology, and does it precede symptom onset?
What This Study Does Not Prove
This study does not prove that anti-5-HT antibodies cause ME/CFS—it only shows association. The cross-sectional design cannot establish causality or determine whether antibodies precede symptom onset. It also does not explain whether serotonin antibodies are primary drivers or secondary consequences of the underlying disease process.